HOXC6 and metastatic colorectal cancer: In colorectal cancer, for example, high HOXC6 expression is highly associated with the remodeling of TME, which can be used as a potential biomarker to predict the efficacy of immunotherapy for non-metastatic colorectal cancer (22).